Cargando…
Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species
INTRODUCTION: Candida species is the common form of opportunistic fungal infections, especially in immunosuppressed individuals. Fluconazole is the first-line therapy for candidiasis as it is affordable and readily available. However, the antifungal resistance pattern in high-risk patients is a majo...
Autores principales: | Paul, Sony, Mohanram, Kalyani, Kannan, Iyanar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454909/ https://www.ncbi.nlm.nih.gov/pubmed/31000996 http://dx.doi.org/10.4103/ayu.AYU_24_18 |
Ejemplares similares
-
Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients
por: Paul, Sony, et al.
Publicado: (2019) -
Molecular identification and antifungal susceptibility pattern of Candida species isolated from HIV infected Patients with candisiasis
por: Paul, Sony, et al.
Publicado: (2019) -
Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin
por: Esfahani, Ava Nasr, et al.
Publicado: (2019) -
Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
por: Tan, Jingwen, et al.
Publicado: (2021) -
In vitro antifungal activities of Euphorbia macroclada and fluconazole against pathogenic Candida species
por: Mahmoudi, S, et al.
Publicado: (2015)